Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marina Scop Medeiros

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
Clinical ManifestationsDouglas Teixeira Leffa, Guilherme Povala, Pamela C L Ferreira, et al.
Molecular Psychiatry|December 14, 2025
In vivo-measured Lewy body pathology is associated with neuropsychiatric symptoms across the Alzheimer's disease continuumDouglas Teixeira Leffa, Guilherme Povala, Pamela C L Ferreira, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Alzheimer's Imaging ConsortiumGuilherme Povala, Bruna Bellaver, Guilherme Bauer-Negrini, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Alzheimer's Imaging ConsortiumCristiano Aguzzoli, Guilherme Povala, Pamela C L Ferreira, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Alzheimer's Imaging ConsortiumPampa Saha, Bruna Bellaver, Guilherme Povala, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
BiomarkersEmma Ruppert, Marina Scop Medeiros, Marie R Vermeiren, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Alzheimer's Imaging ConsortiumEmma Ruppert, Marina Scop Medeiros, Marie R Vermeiren, et al.
Neurology|December 9, 2025
Evaluating Plasma p-tau217 as an Endpoint for Alzheimer Disease Clinical TrialsPamela C L Ferreira, Bruna Bellaver, Guilherme Povala, et al.
The Journal of Prevention of Alzheimer'S Disease|June 5, 2025
Utility of plasma GFAP as a secondary endpoint for clinical trials in Alzheimer's diseaseSarah Abbas, Pamela C L Ferreira, Bruna Bellaver, et al.
JAMA Network Open|November 27, 2023
Neuropsychiatric Symptoms and Microglial Activation in Patients with Alzheimer DiseaseCristiano Schaffer Aguzzoli, Pâmela C L Ferreira, Guilherme Povala, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
Clinical ManifestationsDouglas Teixeira Leffa, Guilherme Povala, Pamela C L Ferreira, et al.
Molecular Psychiatry|December 14, 2025
In vivo-measured Lewy body pathology is associated with neuropsychiatric symptoms across the Alzheimer's disease continuumDouglas Teixeira Leffa, Guilherme Povala, Pamela C L Ferreira, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Alzheimer's Imaging ConsortiumGuilherme Povala, Bruna Bellaver, Guilherme Bauer-Negrini, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Alzheimer's Imaging ConsortiumCristiano Aguzzoli, Guilherme Povala, Pamela C L Ferreira, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Alzheimer's Imaging ConsortiumPampa Saha, Bruna Bellaver, Guilherme Povala, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
BiomarkersEmma Ruppert, Marina Scop Medeiros, Marie R Vermeiren, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Alzheimer's Imaging ConsortiumEmma Ruppert, Marina Scop Medeiros, Marie R Vermeiren, et al.
Neurology|December 9, 2025
Evaluating Plasma p-tau217 as an Endpoint for Alzheimer Disease Clinical TrialsPamela C L Ferreira, Bruna Bellaver, Guilherme Povala, et al.
The Journal of Prevention of Alzheimer'S Disease|June 5, 2025
Utility of plasma GFAP as a secondary endpoint for clinical trials in Alzheimer's diseaseSarah Abbas, Pamela C L Ferreira, Bruna Bellaver, et al.
JAMA Network Open|November 27, 2023
Neuropsychiatric Symptoms and Microglial Activation in Patients with Alzheimer DiseaseCristiano Schaffer Aguzzoli, Pâmela C L Ferreira, Guilherme Povala, et al.
Pageof 2